ORTEXORTEX News
Tracking OHI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
OH
Earnings PreviewOHI

OHI outpaces peers into earnings as short position stabilises

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 4 Nov 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Omega Healthcare Investors gained 3.0% over the past week to $47.53, while the median move across its closest healthcare REIT peers was just 0.1%. SBRA slipped 0.3%, CTRE fell 2.3%, and VTR dropped 0.8%. NHI and HR were the exceptions, rising 1.5% and 6.3% respectively. OHI's outperformance stands against a short position that remains elevated at 5.1% of the free float, roughly 15 million shares, though sellers trimmed about 4.4% over the past week after a sharp build through early October.

That short position has a specific shape worth noting. The bulk of October's accumulation arrived in a single step around October 9, when short shares jumped by more than 1.2 million, and the count has drifted only marginally since. The official FINRA settlement figure puts days to cover at 7.6, one of the higher readings in the healthcare REIT peer group. Yet the lending market shows no stress. Availability is exceptionally loose at 2,481%, meaning the pool holds roughly 25 times more shares than are currently borrowed, and borrow costs, though up 23% over the past month, remain at just 0.46% annually. Shorts are present, but they are not under pressure.

Where analysts stand going into the print reflects the same split. The consensus remains Hold, with a mean target of $51.37 against a current price of $47.53, implying about 8% upside. Citizens upgraded OHI to Market Outperform on October 22. UBS and Barclays both trimmed targets in mid-October while keeping existing ratings, Buy and Underweight respectively. Wells Fargo also cut its target to $46 on October 19, below the current price. The bull case centres on improving operator coverage ratios, active capital deployment and a portfolio that spans both skilled nursing and seniors housing. Bears point to SNF reimbursement risk, operator dependency and the lingering earnings dilution from the CommuniCare portfolio sale, with Barclays maintaining its Underweight view even as OHI climbs.

One factor tilting sentiment more constructively is the earnings momentum profile. OHI ranks in the 95th percentile for EPS surprise and 92nd percentile for 30-day EPS momentum across the ORTEX universe. Wikipedia attention for the company hit a z-score of 4.5 against its own 90-day history as of late October, a notable spike in retail interest relative to the stock's own baseline. BlackRock raised its stake to 12.3% of shares in its most recent 13G/A filing dated October 27, up from 11.3%, adding a marginal institutional tailwind on the register.

Today's print tests whether OHI's outperformance against peers is backed by FFO numbers that justify a stock trading roughly 8% below the analyst consensus target, or whether the residual short position reflects legitimate concerns about operator risk and the reimbursement outlook that the market has not yet fully priced.

Stocks in this article

See the live data behind this article on ORTEX.

Open OHI on ORTEX →

How this article was generated

Generated
4 Nov 2026, 04:07
Data as of
4 Nov 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.